Commercialization Options
Verasonics collaborates with companies around the world to bring new ultrasound-based solutions to market using our industry-leading technology. By reducing the need for specialized developers and custom hardware requirements, commercial licensees achieve substantial savings in development costs and accelerated time to market.
Vantage NXT System with UTA260-S and L11-5 transducer
Leading-Edge Technology
Verasonics provides the foundation upon which great ideas are built. The Vantage NXT Research Ultrasound System enables single developer innovation from concept to validation and allows developers to focus on new application development rather than on ultrasound system design and development. Verasonics’ unique software beamforming architecture is particularly well-suited for ultrasound applications requiring features such as ultra-fast frame rates, high power, high intensity focused ultrasound (HIFU), and/or high frequency. Customers are supported by a world-class team.
| Commercial Technology Licensing Model | OEM Supply Model | |
|---|---|---|
| Software Development | Full access to source code | Compiled MATLAB code |
| Technology Transfers | Source code, detailed hardware designs | Product documentation |
| Development Systems (Purchased from Verasonics) | Vantage NXT Platforms | Vantage NXT Platform |
| Commercial Systems (Purchased from Verasonics’ contract manufacturer) | Vantage NXT System – varies based on commercial requirement | Vantage NXT OEM System |
| License Fees | Monthly fees | N/A |
| Supply Royalties | N/A | Per unit sold |
| Earned Royalties | Per unit sold | N/A |
Proven Success
Verasonics has executed agreements across a broad range of clinical areas, including Focused Ultrasound, Breast Imaging, Renal Denervation, Drug Delivery, and Neurology. Multiple products have received regulatory approval, and others are undergoing clinical trials. Verasonics is interested in exploring technology agreements with companies of all sizes and at all stages.
For more information please send an email to:
[email protected]
Frequently Asked Questions
Does Verasonics license to all countries?
To date, Verasonics has licensed its technology to companies in Japan, Korea, Europe, the UK, and the US. In countries where we are unable to protect our intellectual property (IP) rights, we would require a substantial upfront investment to mitigate IP risks.
What is the program cost structure?
The actual hardware cost is negotiated between the licensee and Verasonics’ contract manufacturer. Verasonics receives a royalty per commercial system transferred, and only provides those details under a non-disclosure agreement.
Do I have to start paying license fees immediately?
Several licensees have developed full prototypes under a standard research license agreement.
A commercial technology license is required to access our hardware designs and source code and to transfer (sell, rent, lease, etc.) our technology. Oftentimes, investors require developers to secure access to our technology prior to investing in development.
What is the commercialization path for a company?
1
University or commercial researcher leverages the flexibility of the Verasonics platform to develop a new application or novel technique.
2
The university technology transfer office or commercial business evaluates market opportunity and establishes NewCo.
3
NewCo negotiates with Verasonics to secure a commercial license or OEM supply arrangement.
4
NewCo performs clinical studies under IRB approval to gather clinical data for the regulatory submission.
5
NewCo embeds the Verasonics solution in the final form factor and launches a commercial product.
Verasonics’ Commercial Technology Licensing Program
July 21, 2022
Presented by Jon K. Daigle, Verasonics President & CEO
Learn more about Verasonics’ Commercial Technology Licensing Program and the advantages it can provide to an R&D team seeking to innovate with ultrasound.
